Lux Ventures IV, L.P.

RXRX

Lux Ventures IV, L.P. serves as 10% Owner at Recursion Pharmaceuticals, Inc. (RXRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$1.80M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$1.80M

Companies Traded

RXRX

Active Period

Apr 2021

1 total trades

Most Recent

Buy RXRX

Apr 20, 2021 · $1.80M

Lux Ventures IV, L.P.'s Insider Trading at Recursion Pharmaceuticals, Inc. (RXRX)

Buys

1 · $1.80M

Sells

0 · $0.00

Total Shares Bought

100,000

Total Shares Sold

RXRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 20, 2021	Buy	100,000	$18.00	$1.80M	100,000

Related Insiders

Christopher Gibson

Director

RXRXSell · Jun 5, 2026

Najat Khan

director, officer: CEO and President

RXRXSell · Jun 5, 2026

Blake Borgeson

Director

RXRXSell · Jun 4, 2026

Namandje Bumpus

director

RXRXSell · Jun 4, 2026

Ben R Taylor

officer: Chief Financial Officer

RXRXSell · Mar 18, 2026

David Hallett

Chief Scientific Officer

RXRXSell · Feb 17, 2026

Explore More Insider Trading Data

RXRX Insider Trading Activity

View all insider trades at Recursion Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity